COVID-19 Variant Immunologic Landscape Trial (COVAIL Trial)

NCT05289037 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1270

Enrollment

NIH

Sponsor class

Conditions

COVID-19

Interventions

DRUG: AS03
BIOLOGICAL: BNT162b2
BIOLOGICAL: BNT162b2 (B.1.1.529)
BIOLOGICAL: BNT162b2 (B.1.351)
BIOLOGICAL: BNT162b2 bivalent (wildtype and Omicron BA.1)
BIOLOGICAL: BNT162b2 bivalent (wildtype and Omicron BA.4/BA.5)
BIOLOGICAL: CoV2 preS dTM [B.1.351]
BIOLOGICAL: CoV2 preS dTM/D614
BIOLOGICAL: CoV2 preS dTM/D614+B.1.351
BIOLOGICAL: mRNA-1273
BIOLOGICAL: mRNA-1273.351
BIOLOGICAL: mRNA-1273.529
BIOLOGICAL: mRNA-1273.617.2
OTHER: Sodium Chloride, 0.9%

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)